Roivant Sciences Ltd.

NASDAQ:ROIV

11.76 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income 4,231.206-1,115.463-924.116-900.233-519.394-749.366
Depreciation & Amortization 22.03618.8575.932000
Deferred Income Tax 0-4.359-5.932000
Stock Based Compensation 199.627217.781564.95684.958122.57258.86
Change In Working Capital 19.0356.34515.71971.93815.29649.673
Accounts Receivables 000000
Inventory 000000
Accounts Payables 22.6844.35915.4033.7526.5984.537
Other Working Capital -3.6491.9860.31668.1868.69845.136
Other Non Cash Items 96.03733.446-334.288191.199-264.332-329.073
Operating Cash Flow -765.268-843.393-677.729-552.138-761.832-1,024.229
Investing Activities:
Investments In Property Plant And Equipment -1.382-12.69-17.436-5.806-4.916-11.396
Acquisitions Net -36.983107.855-0.03901,771.691-2.599
Purchases Of Investments 000.039-28.25-68.376-43.613
Sales Maturities Of Investments 5,233.3960320.17016.4446.212
Other Investing Activites 5,241.988-139.4340.5612.354-20.049-46.212
Investing Cash Flow 5,203.623-44.269303.295-31.7021,694.79-57.608
Financing Activities:
Debt Repayment -30.705-127.505-21.590-32.063-9.707
Common Stock Issued 438.555382.838313.424455.7561,354.21598.856
Common Stock Repurchased 0.951-10.8810-0.113-1,188.465-7.375
Dividends Paid -600000
Other Financing Activities -43.756-10.88114.9580.62183.481185.243
Financing Cash Flow 419.364499.462306.792456.264217.163767.017
Other Information:
Effect Of Forex Changes On Cash 0.6166.2810001,433.951
Net Change In Cash 4,858.335-381.919-67.642-127.5761,335.9311,119.131
Cash At End Of Period 6,550.451,692.1152,074.0342,141.6762,185.482849.551